Drug Profile
SGN 15
Alternative Names: BR96-DAPDOX; cBR96-Doxorubicin Immunoconjugate; SGN-15Latest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Anthracyclines; Cytostatic antibiotics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Reactive oxygen species stimulants; RNA synthesis inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Non-small cell lung cancer; Ovarian cancer; Prostate cancer